Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
130M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
31.4M
-
Shares change
-
+2.14M
-
Total reported value, excl. options
-
$216M
-
Value change
-
+$14.6M
-
Number of buys
-
20
-
Number of sells
-
-3
-
Price
-
$6.86
Significant Holders of PROKIDNEY CORP. - Ordinary Shares (PROK) as of Q4 2022
28 filings reported holding PROK - PROKIDNEY CORP. - Ordinary Shares as of Q4 2022.
PROKIDNEY CORP. - Ordinary Shares (PROK) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.4M shares
of 130M outstanding shares and own 24.21% of the company stock.
Largest 10 shareholders include Social Capital Group LLC (13.3M shares), MORGAN STANLEY (10.9M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.19M shares), Bleichroeder LP (2M shares), Brown University (1M shares), BlackRock Inc. (206K shares), BANK OF AMERICA CORP /DE/ (196K shares), VANGUARD GROUP INC (183K shares), GEODE CAPITAL MANAGEMENT, LLC (133K shares), and Swiss National Bank (74.3K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.